FDA ODAC Meeting Material discussion analysis, page-165

  1. 11,515 Posts.
    lightbulb Created with Sketch. 517
    It appears to me this is the FDA covering there backside so to speak and ensuring expert panel discuss older trial results.

    Everything must be discussed.

    FDA conclusion on safety and efficiency is the statement of what they are thinking pre meeting. Imo.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.31
Change
-0.100(4.15%)
Mkt cap ! $2.956B
Open High Low Value Volume
$2.33 $2.35 $2.15 $30.94M 13.57M

Buyers (Bids)

No. Vol. Price($)
5 75954 $2.30
 

Sellers (Offers)

Price($) Vol. No.
$2.32 10350 2
View Market Depth
Last trade - 16.17pm 21/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.